Betnovate RD 0.025% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betnovate rd 0.025% ointment

glaxosmithkline uk ltd - betamethasone valerate - cutaneous ointment - 250microgram/1gram

BETNOVATE Cream Australia - English - Department of Health (Therapeutic Goods Administration)

betnovate cream

aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 1.21 mg/g (equivalent: betamethasone, qty 1 mg/g) - cream - excipient ingredients: purified water; white soft paraffin; liquid paraffin; chlorocresol; cetostearyl alcohol; cetomacrogol 1000; monobasic sodium phosphate; phosphoric acid; sodium hydroxide - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.

Audavate 0.1% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

audavate 0.1% ointment

accord-uk ltd - betamethasone valerate - cutaneous ointment - 1mg/1gram

Betnovate Australia - English - Department of Health (Therapeutic Goods Administration)

betnovate

aspen pharma pty ltd - betamethasone valerate -

BETNOVATE N Ireland - English - HPRA (Health Products Regulatory Authority)

betnovate n

glaxo laboratories limited - betamethasone valerate neomycin sulfate - ointment - 0.1/0.5 %w/w

BETNOVATE N 0.1/0.5 %w/w Ointment Ireland - English - HPRA (Health Products Regulatory Authority)

betnovate n 0.1/0.5 %w/w ointment

glaxo laboratories limited - betamethasone valerate neomycin sulfate - ointment - 0.1/0.5 %w/w

BETNOVATE OINTMENT Israel - English - Ministry of Health

betnovate ointment

glaxo smith kline (israel) ltd - betamethasone as valerate - ointment - betamethasone as valerate 0.1 %w/w - betamethasone - betamethasone - betamethasone valerate is a potent topical corticosteroid indicated for adults, elderly and children over 1 year for the relief of the inflammatory and pruritic manifestations of steroid responsive dermatoses.these include the following:atopic dermatitis (including infantile atopic dermatitis)nummular dermatitis (discoid eczema)prurigo nodularispsoriasis (excluding widespread plaque psoriasis)lichen simplex chronicus (neurodermatitis) and lichen planusseborrhoeic dermatitisirritant or allergic contact dermatitisdiscoid lupus erythematosusadjunct to systemic steroid therapy in generalised erythroderma

Betnovate 0.1% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betnovate 0.1% ointment

glaxosmithkline uk ltd - betamethasone valerate - cutaneous ointment - 1mg/1gram

Audavate RD 0.025% ointment United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

audavate rd 0.025% ointment

accord-uk ltd - betamethasone valerate - cutaneous ointment - 250microgram/1gram

Betnovate C New Zealand - English - Medsafe (Medicines Safety Authority)

betnovate c

glaxosmithkline nz limited - betamethasone valerate 0.1%{relative}; clioquinol 3%{relative};   - topical cream - 0.1%/3% - active: betamethasone valerate 0.1%{relative} clioquinol 3%{relative}   - betnovate-c preparations are indicated for the treatment of the following conditions where secondary bacterial and/or fungal infection is present, suspected or likely to occur:- eczema including atopic, and discoid eczemas. prurigo nodularis. psoriasis (excluding widespread plaque psoriasis). neurodermatoses including lichen simplex, lichen planus. seborrhoeic dermatitis. contact sensitivity reactions. insect bite reactions. prickly heat. anal and genital intertrigo. otitis externa.